These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2261853)

  • 1. Insulin release and peripheral sensitivity at the oral glucose tolerance test.
    Cederholm J; Wibell L
    Diabetes Res Clin Pract; 1990 Oct; 10(2):167-75. PubMed ID: 2261853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of insulin release and relative peripheral resistance with use of the oral glucose tolerance test: a study in subjects with normoglycaemia, glucose intolerance and non-insulin-dependent diabetes mellitus.
    Cederholm J; Wibell L
    Scand J Clin Lab Invest; 1985 Dec; 45(8):741-51. PubMed ID: 3909372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
    Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
    Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.
    Matsumoto K; Miyake S; Yano M; Ueki Y; Yamaguchi Y; Akazawa S; Tominaga Y
    Diabetes Care; 1997 Oct; 20(10):1562-8. PubMed ID: 9314636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of treatment on insulin release and relative peripheral resistance during the oral glucose tolerance test. A study of noninsulin-dependent diabetes mellitus and glucose intolerance.
    Cederholm J; Wibell L
    Diabete Metab; 1986 Feb; 12(1):10-5. PubMed ID: 3516748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabetes: new insights on mechanisms of action.
    Osei K; Rhinesmith S; Gaillard T; Schuster D
    Metabolism; 2003 May; 52(5):565-72. PubMed ID: 12759885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes.
    Ludvik B; Lell B; Hartter E; Schnack C; Prager R
    Diabetes; 1991 Dec; 40(12):1615-9. PubMed ID: 1756902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial metabolic effects of chronic glipizide in obese African Americans with impaired glucose tolerance: implications for primary prevention of type 2 diabetes.
    Osei K; Rhinesmith S; Gaillard T; Schuster D
    Metabolism; 2004 Apr; 53(4):414-22. PubMed ID: 15045685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study.
    Saad MF; Anderson RL; Laws A; Watanabe RM; Kades WW; Chen YD; Sands RE; Pei D; Savage PJ; Bergman RN
    Diabetes; 1994 Sep; 43(9):1114-21. PubMed ID: 8070611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
    Enoki S; Mitsukawa T; Takemura J; Nakazato M; Aburaya J; Toshimori H; Matsukara S
    Diabetes Res Clin Pract; 1992 Jan; 15(1):97-102. PubMed ID: 1541241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance.
    Ehrmann DA; Breda E; Cavaghan MK; Bajramovic S; Imperial J; Toffolo G; Cobelli C; Polonsky KS
    Diabetologia; 2002 Apr; 45(4):509-17. PubMed ID: 12032626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test.
    Mari A; Pacini G; Murphy E; Ludvik B; Nolan JJ
    Diabetes Care; 2001 Mar; 24(3):539-48. PubMed ID: 11289482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus.
    Kosaka K; Kuzuya T; Hagura R; Yoshinaga H
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S109-19. PubMed ID: 8894494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
    Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients.
    Muscelli E; Mari A; Casolaro A; Camastra S; Seghieri G; Gastaldelli A; Holst JJ; Ferrannini E
    Diabetes; 2008 May; 57(5):1340-8. PubMed ID: 18162504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Massive weight loss does not restore normal insulin secretory pulses in obese patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Guichard-Rode S; Charrie A; Penet D; Teboul F; Thivolet C
    Diabetes Metab; 1997 Dec; 23(6):506-10. PubMed ID: 9496556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
    Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between insulin resistance and insulin secretion in Japanese subjects with borderline glucose intolerance.
    Wasada T; Arii H; Kuroki H; Saeki A; Katsumori K; Saito S; Omori Y
    Diabetes Res Clin Pract; 1995 Oct; 30(1):53-7. PubMed ID: 8745206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of insulin sensitivity and secretion with the labelled intravenous glucose tolerance test: improved modelling analysis.
    Mari A
    Diabetologia; 1998 Sep; 41(9):1029-39. PubMed ID: 9754821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients.
    Madhu SV; Muduli SK; Avasthi R
    Diabetes Technol Ther; 2013 Jun; 15(6):461-5. PubMed ID: 23631606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.